Cite
Kong CL, Kelly NK, Sundararajan M, et al. Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial. Ocul Immunol Inflamm. 2020;1-5doi: 10.1080/09273948.2020.1774906.
Kong, C. L., Kelly, N. K., Sundararajan, M., Rathinam, S. R., Gonzales, J. A., Thundikandy, R., Vedhanayaki, R., Kanakath, A., Murugan, B., Doan, T., Goldstein, D., Al-Dhibi, H. A., & Acharya, N. R. (2020). Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial. Ocular immunology and inflammation, 1-5. https://doi.org/10.1080/09273948.2020.1774906
Kong, Christina L, et al. "Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial." Ocular immunology and inflammation vol. (2020): 1-5. doi: https://doi.org/10.1080/09273948.2020.1774906
Kong CL, Kelly NK, Sundararajan M, Rathinam SR, Gonzales JA, Thundikandy R, Vedhanayaki R, Kanakath A, Murugan B, Doan T, Goldstein D, Al-Dhibi HA, Acharya NR. Comparison of CD4 Counts with Mycophenolate Mofetil versus Methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial. Ocul Immunol Inflamm. 2020 Aug 11;1-5. doi: 10.1080/09273948.2020.1774906. Epub 2020 Aug 11. PMID: 32779952; PMCID: PMC7876156.
Copy
Download .nbib